Lineage Cell Therapeutics, Inc. LCTX
HEALTHCARE · BIOTECHNOLOGYi
Market datapartial · fetched 2026-11-13T02:05:58.782Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-13T01:00:00.080120092Z
FundamentalsAlpha Vantage · ready · quarter 2026-06-30 · fetched 2026-11-13T02:03:44.859004+00:00
Lineage Cell Therapeutics, Inc. options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 5.33 | 800.0% | 488.5% | |||
| 25Δ | 4.74 | 800.0% | 430.2% | |||
| 30Δ | 4.40 | 800.0% | 397.7% | |||
| 35Δ | 4.06 | 800.0% | 365.1% | |||
| 40Δ | 3.73 | 800.0% | 332.6% | |||
| 45Δ | 3.39 | 800.0% | 300.1% | |||
| 50Δ | 3.05 | 800.0% | 267.6% | |||
| 55Δ | 2.72 | 800.0% | 235.1% | |||
| 60Δ | 2.38 | 800.0% | 202.5% | |||
| 65Δ | 2.04 | 800.0% | 170.0% | |||
| 70Δ | 1.71 | 800.0% | 137.5% | |||
| 75Δ | 1.37 | 800.0% | 105.0% | |||
| 80Δ | 1.03 | 800.0% | 72.4% | |||
20Δ
- Pseudo strike
- 5.33
- IV
- 800.0%
- B/E move
- 488.5%
- Pseudo strike
- IV
- B/E move
25Δ
- Pseudo strike
- 4.74
- IV
- 800.0%
- B/E move
- 430.2%
- Pseudo strike
- IV
- B/E move
30Δ
- Pseudo strike
- 4.40
- IV
- 800.0%
- B/E move
- 397.7%
- Pseudo strike
- IV
- B/E move
35Δ
- Pseudo strike
- 4.06
- IV
- 800.0%
- B/E move
- 365.1%
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- 3.73
- IV
- 800.0%
- B/E move
- 332.6%
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- 3.39
- IV
- 800.0%
- B/E move
- 300.1%
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- 3.05
- IV
- 800.0%
- B/E move
- 267.6%
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- 2.72
- IV
- 800.0%
- B/E move
- 235.1%
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- 2.38
- IV
- 800.0%
- B/E move
- 202.5%
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- 2.04
- IV
- 800.0%
- B/E move
- 170.0%
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- 1.71
- IV
- 800.0%
- B/E move
- 137.5%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- 1.37
- IV
- 800.0%
- B/E move
- 105.0%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 1.03
- IV
- 800.0%
- B/E move
- 72.4%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 234.36% | |
| 207.32% | |
| 303.62% | |
| 288.61% |
Biotechnology
LEGN
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of new cell therapies for oncology and other indications in…
More →LENZ
LENZ Therapeutics Inc is a cutting-edge biopharmaceutical company dedicated to developing transformative therapies for neurological disorders, specifically targeting critical…
More →LGND
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies discover and develop drugs…
More →LITS
Lite Strategy, Inc. a clinical-stage pharmaceutical company, focuses on the development of various therapies for the treatment of cancer. The company is headquartered in San…
More →LKFT
Lakefront Biotherapeutics NV (LKFT) is an innovative biopharmaceutical company focused on addressing significant unmet medical needs in oncology and infectious diseases through…
More →LRMR
Larimar Therapeutics, Inc., a clinical-stage biotechnology company, is focused on developing treatments for rare diseases. The company is headquartered in Bala Cynwyd,…
More →